Abound Wealth Management Ironwood Pharmaceuticals Inc Transaction History
Abound Wealth Management
- $271 Billion
- Q2 2024
A detailed history of Abound Wealth Management transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Abound Wealth Management holds 34 shares of IRWD stock, worth $153. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34
Previous 34
-0.0%
Holding current value
$153
Previous $297,000
25.25%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding IRWD
# of Institutions
247Shares Held
171MCall Options Held
11.2MPut Options Held
28.5K-
Black Rock Inc. New York, NY22.9MShares$103 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$97.5 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$74.1 Million18.04% of portfolio
-
State Street Corp Boston, MA9.24MShares$41.8 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA8.91MShares$40.3 Million0.15% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $693M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...